Artificial Bone Market to Surpass US$ 1,916.0 Million by 2027 - Coherent Market Insights

Global Artificial Bone Market, By Material (Ceramics, Composite, Polymer, Hydroxyapatite, and Others), By Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, and Trauma and Extremities), By End User (Hospitals, Specialty Clinics, and Research Organization), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,308.2 million in 2020 and is expected to exhibit a CAGR of 5.6% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The companies are focusing on launching new products, in order to expand their product portfolio and strengthen their presence in the market, which is expected to drive growth of the artificial bone market over the forecast period. For instance, in May 2016, NuVasive, Inc. launched AttraX Putty, a next-generation, synthetic bone graft product, developed to be used as an autograft extender in posterolateral spine surgery.

Global Artificial Bone Market – Impact of Coronavirus (Covid-19) Pandemic

On April 30, 2020, the American Academy of Orthopedic Surgeons published clinical considerations for its members to tackle the COVID-19 pandemic situation. Following are the guidelines provided by the American Academy of Orthopedic Surgeons to navigate through the COVID-19 pandemic:

• First Priority: Safety of patients is considered to be the top most priority
• Second Priority: Safety of health care personnel and staff
• The members of American Academy of Orthopedic Surgeons should adhere to Centers for Disease Control Prevention (CDC), and relevant federal, state, and local public

health guidance and recommendations

• The table below outlines a possible framework for clinical activities that can be separated into the following categories based on appropriate state and local level public health guidance:

Browse 35 Market Data Tables and 34 Figures spread through 198 Pages and in-depth TOC on “Artificial Bone Market - By Material (Ceramics, Composite, Polymer, Hydroxyapatite, and Others), By Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, and Trauma and Extremities), By End User (Hospitals, Specialty Clinics, and Research Organization), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027”

To know the latest trends and insights prevalent in the global artificial bone market, click the link below:

https://www.coherentmarketinsights.com/market-insight/artificial-bone-market-1899

The rising incidence of injuries/trauma is expected to propel growth of the artificial bone market. For instance, according to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer from moderate to severe injuries such as bruises, hip fractures or head trauma in the U.S. Moreover, according to the Centers for Disease Control and Prevention, around 800,000 cases are recorded for head injuries or hip fractures every year in the U.S. and around 300,000 cases of hip fractures in people of age 65 and above are observed every year in the U.S.

Key Takeaways of the Global Artificial Bone Market:

• The global artificial bone market is expected to exhibit a CAGR of 5.6% over the forecast period, owing to increasing number of fractures. For instance, in February 2019, National Hip Fracture Database Annual Report 2018 estimated that around 76,000 hip fractures occur in the U.K. every year.
• Among application, the spinal fusion segment held a dominant position in the artificial bone market in 2019, owing to increasing product launches by market players. For instance, in August 2020, Xtant Medical Holdings, Inc. announced the launch of Matriform Si, a synthetic bone graft strip developed for the spinal fusion procedures.
• Key players operating in the global artificial bone market include Johnson & Johnson (DePuy Synthes), Baxter International Inc., Medtronic Plc, Stryker Corporation, Orthofix International N.V., AlloSource, Inc., NuVasive, Inc., Smith & Nephew plc, DSM, Biomatlante, Curasan, Inc., and Ziacom Medical